154 related articles for article (PubMed ID: 16491484)
1. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
Das GC; Bacsi A; Shrivastav M; Hazra TK; Boldogh I
Mol Carcinog; 2006 Sep; 45(9):635-47. PubMed ID: 16491484
[TBL] [Abstract][Full Text] [Related]
2. Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress.
Boldogh I; Roy G; Lee MS; Bacsi A; Hazra TK; Bhakat KK; Das GC; Mitra S
Toxicology; 2003 Nov; 193(1-2):137-52. PubMed ID: 14599773
[TBL] [Abstract][Full Text] [Related]
3. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
[TBL] [Abstract][Full Text] [Related]
4. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L
Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
[TBL] [Abstract][Full Text] [Related]
6. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
Bailey HH; Gipp JJ; Ripple M; Wilding G; Mulcahy RT
Cancer Res; 1992 Sep; 52(18):5115-8. PubMed ID: 1355406
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.
Kurokawa H; Ishida T; Nishio K; Arioka H; Sata M; Fukumoto H; Miura M; Saijo N
Biochem Biophys Res Commun; 1995 Nov; 216(1):258-64. PubMed ID: 7488097
[TBL] [Abstract][Full Text] [Related]
8. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins.
Iida T; Kijima H; Urata Y; Goto S; Ihara Y; Oka M; Kohno S; Scanlon KJ; Kondo T
Cancer Gene Ther; 2001 Oct; 8(10):803-14. PubMed ID: 11687904
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.
Tipnis SR; Blake DG; Shepherd AG; McLellan LI
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):559-66. PubMed ID: 9895302
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
Horton JK; Roy G; Piper JT; Van Houten B; Awasthi YC; Mitra S; Alaoui-Jamali MA; Boldogh I; Singhal SS
Biochem Pharmacol; 1999 Aug; 58(4):693-702. PubMed ID: 10413308
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
Hector S; Nava ME; Clark K; Murphy M; Pendyala L
Cancer Lett; 2007 Jan; 245(1-2):195-204. PubMed ID: 16516375
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase.
Morales A; García-Ruiz C; Miranda M; Marí M; Colell A; Ardite E; Fernández-Checa JC
J Biol Chem; 1997 Nov; 272(48):30371-9. PubMed ID: 9374527
[TBL] [Abstract][Full Text] [Related]
13. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
[TBL] [Abstract][Full Text] [Related]
14. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
Mulcahy RT; Untawale S; Gipp JJ
Mol Pharmacol; 1994 Nov; 46(5):909-14. PubMed ID: 7969079
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
[TBL] [Abstract][Full Text] [Related]
17. Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells.
Lin T; Yang MS
Toxicology; 2007 Jun; 235(1-2):1-10. PubMed ID: 17416446
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.
Benassi B; Zupi G; Biroccio A
Mol Pharmacol; 2007 Oct; 72(4):1015-23. PubMed ID: 17628013
[TBL] [Abstract][Full Text] [Related]
19. Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells.
Ray S; Watkins DN; Misso NL; Thompson PJ
Clin Exp Allergy; 2002 Apr; 32(4):571-7. PubMed ID: 11972604
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.
Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Takagi A; Miwa T; Mine T; Yamazaki H; Nakamura M; Kondo T; Scanlon KJ; Ueyama Y
Biochem Biophys Res Commun; 2001 Aug; 286(2):406-13. PubMed ID: 11500053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
